DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis
Zhou, J, Ning, Z, Wang, B, Yun, E-J, Zhang, T, Pong, R-C, Fazli, L, Gleave, M, Zeng, J, Fan, J, Wang, X, Li, L, Hsieh, J-T, He, D, Wu, KVolume:
6
Language:
english
Journal:
Cell Death and Disease
DOI:
10.1038/cddis.2015.289
Date:
October, 2015
File:
PDF, 2.89 MB
english, 2015